Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

about

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

Item

http://www.wikidata.org/entity/Q36714499

description

1981 nî lūn-bûn

@nan

1981年の論文

@ja

1981年論文

@yue

1981年論文

@zh-hant

1981年論文

@zh-hk

1981年論文

@zh-mo

1981年論文

@zh-tw

1981年论文

@wuu

1981年论文

@zh

1981年论文

@zh-cn

name

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

@ast

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

@en

type

Item

label

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

@ast

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

@en

prefLabel

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

@ast

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

@en

P1476

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

@en

P2093

Marsh FP

http://www.w3.org/2001/XMLSchema#string

Morton JJ

http://www.w3.org/2001/XMLSchema#string

Sharman VL

http://www.w3.org/2001/XMLSchema#string

VandenBurg MJ

http://www.w3.org/2001/XMLSchema#string

Williams GH

http://www.w3.org/2001/XMLSchema#string

P2860

The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.

Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.

Accentuated vascular and endocrine response to SQ 20881 in hypertension.

The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.

Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.

Angiotensin I converting enzyme.

Inhibition of angiotensin conversion and prevention of renal hypertension.

Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor.

The cost of scientific communication: the scientist as ad-man.

P304

283-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/PGMJ.57.667.283

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

667

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1981-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51283303

http://www.w3.org/2001/XMLSchema#string

P698

6170971

http://www.w3.org/2001/XMLSchema#string

P932

2424921

http://www.w3.org/2001/XMLSchema#string